Research Center
Latest News
Company Profile
Stock information
Business Relationship
Financial Results
Home > About Hanmi > Affiliates
Established in 1984 with the purpose of manufacturing Active Pharmaceutical Ingredients, Hanmi Fine Chemical was successful in the development of third generation cephalosporin through ceaseless research activities and enormous facility investment.

Many of the products are independently developed by the research staff and their quality has been globally recognized. With its expertise on synthesis of bulk products from laboratory to plant level, the company is pushing ahead with a plan to develop diverse technologies while concentrating its efforts on the first generic strategy and forming strategic alliances with other global companies.

President J.G. KOH Address : 1248-8,Chungwang-Dong,Shiheung-City,Kyonggi-Do, KOREA
Tel No : 82 31 499 2541~4
Fax No : 82 31 499 2540

http://www.hanmifc.co.kr
Beijing Hanmi Pharmaceutical is a joint-venture company established in March 1996 by Beijing Third Pharmaceutical Company and Hanmi with a joint investment.

The GMP plant, which was completed in the first half of 2001 with total construction expense reaching 7 million US dollars, has a ground area of 8,000 square meters. After gaining the GMP approval from the Chinese authorities in July 2002, the plant has produced a variety of products.

As of 2007, Beijing Hanmi has a total of 510 employees including medical doctors and pharmacists. The company obtained the drug import license for six items and plans to increase the number. Reaching a near 50 percent increase in annual sales through countries new product launches and its widely structured sales network covering the mainland, Beijing Hanmi steps closer to the goal of becoming a leader in China.

Address : Room 907,Beijing Golden Land Building,No.32 Liang Ma Qiao Road, Chaoyang Diserice,Beijing,China
Tel No : 86 10 6464 343
5 Fax No : 86 10 6464 3406

http://www.bjhanmi.com.cn

Hanmi Japan Pharmaceutical was established in 2007 with the purpose of focusing on the pharmaceutical business in Japan. Hanmi Japan Pharmaceutical has been exploring business opportunity of LAPSCOVERY(Long Acting discovery technology), ORASCOVERY(Oral drug Discovery technology) and Super Generic in Japanese market based on R&D capability Hanmi Pharmaceutical has achieved so far.

Accordingly, Hanmi Japan has built up a wide business relationship with major pharmaceutical companies in Japan regarding mutual Licensing activities since its establishment.

Address : Aspa Nihonbashi office 301, Nihonbashi Hongoku-cho, Chuo-ku, Tokyo, Japan
Zip code : 103-0021
Tel : 81-03-6225-5991ˇˇFax : 81-03-6225-5992

Established in 1998 and has been focused on manufacturing and marketing of beverages including soybean milk, healthcare foods and over the counter products in Korea. Hanmi FT is pursuing to be a leader in this industry by focusing on development of new product and through the full automation in all production process.
Established in 2005 and has been focused on the development of enterprise solution, consulting, and total outsourcing of enterprise network. Based on know-how acquired through having built a computerized environment for a variety of companies, Hanmi IT is proceeding toward system integration such as operating portal sites for pharmacists, doctors and hospitals, mobile phone business in China, RFID, and the development of mobile middleware.
Established in 2005 with the purpose of marketing of medical devices and wound care goods in Korean. The main products are QFlowTM500 (measurement of blood flow quantity), Guardix-solutions(anti-adhesion), Carefoam, Arino (wound care) and so on.